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Embryonic lungs must be inflated immediately after birth to establish respiration. In
addition to pulmonary surfactant, recently, we have revealed lymphatic function as a
previously unknown regulator of prenatal lung compliance that prepares the embryonic
lung for inflation at birth. It is well-documented that the late gestation embryo performs
episodic breathing-like movements called as fetal breathing movements (FBMs), but
the physiological importance of these events is not clear. Here we aimed to study
the physiological role of FBMs in preparation for air inflation at birth. Clp1K/K late
gestation embryos develop a progressive loss of spinal motor neurons associated
with axonal degeneration and denervation of neuromuscular junctions serving as an
ideal genetic model to test the possible role of FBMs. We demonstrated that Clp1K/K
newborns show impaired motor function resulting in fatal respiratory failure after birth.
Next, we showed that the alveolar septa are thicker, and the alveolar area is reduced
in Clp1K/K late gestation embryos, while the expression of molecular markers of lung
development are not affected. Importantly, pulmonary lymphatic vessels are dilated and
the prenatal pulmonary lymphatic function is reduced in Clp1K/K late gestation embryos.
Our results have revealed that Clp1K/K mice show impaired motor functions including
FBMs, and late gestation Clp1K/K embryos display reduced prenatal lymphatic function
and impaired lung expansion represented as thickened alveolar septa and reduced
alveolar area in preparation of the developing lung for inflation at birth. These findings
suggest a possible mechanism that FBMs, similarly to breathing movements after birth,
stimulate prenatal lymphatic function in pulmonary collecting lymphatics lacking smooth
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muscle coverage to prepare the developing lung for inflation and gas exchange at
birth. Moreover, these results raise the possibility that stimulating FBMs during late
gestation might be an effective way to reduce the risk of the development of neonatal
respiratory failure.
Keywords: fetal breathing movements, pulmonary lymphatics, lung development, genetic mouse models, organ-
specific lymphatic function
INTRODUCTION
Embryonic lungs develop in a fluid compartment in utero and
must be inflated immediately after birth to establish respiration.
A complex developmental program prepares the fluid-filled
embryonic lung for the postnatal life (Morrisey and Hogan, 2010;
Nikolic et al., 2018; Whitsett et al., 2019). After the pulmonary
developmental program is completed the first breaths require
much greater forces to inflate the lung and establish respiration
than the subsequent breathing movements (Milner and Sauders,
1977; Hall, 2016). Pulmonary surfactant secreted by type II
pneumocytes is a well-known regulator of pulmonary compliance
and lung inflation at birth (Morgan, 1971). In connection,
the current therapeutic approaches mainly focus on inducing
and stimulating surfactant production and the possible ways of
surfactant substitution in preterm infants and newborns with
respiratory distress syndrome (Couser et al., 1990; Nouraeyan
et al., 2014; Polin and Carlo, 2014).
In addition to surfactant, our recent studies have revealed
the importance of prenatal lymphatic function as a regulator of
lung inflation at birth by inducing the expansion and increasing
the compliance of the developing lung in preparation for the
first breath (Jakus et al., 2014). It was shown before that LECs
are present in the developing lung at E12.5, which form lumen
by E14.5 in mouse embryos (Kulkarni et al., 2011), but the
function of these lymphatic structures was unclear. Our studies
indicated that parallel mechanisms, which include prenatal
lymphatic function are involved in the preparation of the prenatal
lung for inflation at birth (Jakus et al., 2014; Aspelund et al.,
2016). Recent studies demonstrated that the structure of the
pulmonary collecting lymphatic vessels is different compared to
other lymphatic collectors in different organs, which are covered
by smooth muscle cells providing the pumping function and
maintaining the forward flow of the lymph fluid with the help
of the lymphatic valves (Maby-El Hajjami and Petrova, 2008). In
contrast to the other organs the collecting lymphatics in the lung
do not have smooth muscle coverage (Outtz Reed et al., 2019).
Therefore, it is essential to have an independent mechanism in
the lung which provides the pumping function and maintains
the lymph flow. Breathing is always present in the adult lung to
Abbreviations: α-SMA, α-smooth muscle actin; CC10, club cell 10 (Clara cell 10);
DAPI, 4′,6-diamidino-2-phenylindole; E, embryonic day; FBMs, fetal breathing
movements; HE, hematoxylin eosin; LEC, lymphatic endothelial cell; LYVE1,
lymphatic vessel endothelial hyaluronan receptor 1; NG2, neuron–glial antigen 2;
P, postnatal day; PBS, phosphate-buffered saline; PDGFRα, platelet-derived growth
factor receptor α; PDGFRβ, platelet-derived growth factor receptor β; PDPN,
podoplanin; PECAM1, platelet endothelial cell adhesion molecule 1; PROX1,
prospero homeobox 1; RhD, phodamine-dextran; SPC, prosurfactant protein C;
VEGFR3, vascular endothelial growth factor receptor 3.
stimulate the lymph flow of pulmonary lymphatic vessels (Outtz
Reed et al., 2019), but it is an open question how lymph flow is
induced and maintained in the developing lung in the lack of
smooth muscle coverage of collecting lymphatics.
Early studies suggested that fluid secretion and mechanical
forces influence the expansion and developmental process of
the embryonic lung (Perlman et al., 1976; Wigglesworth and
Desai, 1982; Moessinger et al., 1990; Harding and Hooper, 1996;
Kitterman, 1996). It has been shown that prolonged leakage of the
amniotic fluid results in a collapsed lung phenotype, which was
referred as lung hypoplasia (Perlman et al., 1976). In connection
to this, a more recent study indicated that mechanical forces
induced by amniotic fluid inhalation influence the differentiation
of type II and type I pneumocytes (Li et al., 2018).
It is well known that the late gestation embryo performs
periodic breathing-like movements during late gestation which
are called as FBMs. In connection to their possible function,
altered lung development was detected in human fetuses with
skeletal muscle defects, which changes of lung morphology were
referred as lung hypoplasia (Sandler et al., 1994). However,
these paralyzed embryos appeared to be much smaller than the
embryos with normal skeletal muscle function, which finding
indicates that the defect of skeletal muscle innervation starting
from the early life period significantly influences the size and
growth rate of the embryo. Therefore, based on these prior
studies the possible physiological role of periodic FBMs during
late gestation remains unclear.
To define the role of FBMs on prenatal lung development,
surgical approaches including phrenic nerve section and spinal
cord transection were also applied in lamb embryos (Fewell et al.,
1981; Liggins et al., 1981). These heroic studies involving the
surgical manipulation of the embryos in the womb indicated
that transection of the spinal cord above the phrenic nucleus or
the section of phrenic nerve results in reduced lung expansion
with reduced wet lung weights (Fewell et al., 1981; Liggins
et al., 1981). Based on the results the authors concluded that
the lack of FBMs leads to lung hypoplasia, which became
a widely accepted paradigm. However, if we analyze these
studies in detail we will find that the dry weights of the lungs
were not reduced after the surgical procedures, questioning the
main concept about lung hypoplasia (Fewell et al., 1981). In
addition, reports aiming to repeat the phrenic nerve section
studies in more controlled experiments in lambs found that the
complicated surgical procedure in sham operated animals has
more pronounced effect on the morphology of the developing
lung than the phrenic nerve section itself (Bamford et al.,
1992). Therefore, the authors concluded that phrenic nerve
section does not cause the hypoplasia of the developing lung
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(Bamford et al., 1992). Important to note that not only large
animals and humans but mouse embryos also perform FBMs
during late gestation (Niblock et al., 2020). As another approach,
a mouse model was reported in which myogenin deficiency leads
to the disruption of normal skeletal muscle structure (Tseng
et al., 2000). The authors concluded the presence of pulmonary
hypoplasia in this model, but it is important to consider that the
skeletal muscles are affected from the early embryonic period,
therefore not only the FBMs but the overall growth rate of the
embryo is also altered in the model (Tseng et al., 2000).
Based on the above studies it is suggested that mechanical
forces generated by FBMs influence the developmental process
of the prenatal lung. However, all the experimental systems used
in these prior studies answer different questions or have great
limitations. Leakage or drainage of the amniotic fluid may affect
not only FBMs but also the volume and function of the organs,
embryos paralyzed from the early embryonic period show severe
defects of the skeleton which is represented in their smaller
size and reduced growth, and surgical approaches destroying the
spinal cord or phrenic nerve are heroic and may influence a
number of physiological processes in addition to FBMs.
Recently Hanada et al. (2013) studied the phenotype of
Clp1K/K embryos carrying a kinase-dead CLP1 RNA kinase,
these embryos develop a progressive loss of spinal motor
neurons associated with axonal degeneration and denervation
of neuromuscular junctions at E16.5 onward including the
respiratory skeletal muscles (diaphragm etc.). The denervation
causes impaired motor function, weakness of the skeletal muscles,
paralysis, and respiratory failure at birth (Hanada et al., 2013).
It has also been demonstrated that CLP1 has an important
function in the motor neurons, where the loss of CLP1 activity
induces the accumulation of small RNA fragments because of the
abnormal processing of tyrosine pre-transfer RNA. The elevated
levels of the tRNA fragments lead to oxidative-stress-mediated
p53 activation and p53-dependent elimination of motor neurons
(Hanada et al., 2013).
Herein, we aimed to use the Clp1K/K model as a genetic model
with skeletal muscle denervation including the diaphragm at
E16.5 onward (Hanada et al., 2013) to test the possible role of
FBMs in preparation for air inflation at birth in experimental
mice. Our studies indicate that Clp1K/K embryos displaying
impaired motor functions and FBMs show reduced prenatal
lung expansion without significantly affecting the molecular
and cellular lung development during the embryonic period.
Importantly, our results suggest a possible mechanism that
one of the main functions of FBMs is to stimulate prenatal
pulmonary lymphatic function in pulmonary lymphatic vessels
lacking smooth muscle coverage and increase prenatal lung
expansion in preparation for lung inflation at birth.
MATERIALS AND METHODS
Animals
Mice carrying the kinase-dead Clp1 allele (Clp1K) (Hanada
et al., 2013) were maintained on a c57Bl/6 and a c57Bl/6-
NMRI mixed genetic backgrounds. The embryos and newborns
of heterozygous matings were genotyped by allele-specific PCR
using 5′-TTG GTT CAG GTA TTA AGT CGT TGG-3′ forward
and 5′-GAA TTG CAT AGT CTT TCC TCC ATC-3′ reverse
primers. Flt4YFP mice (Calvo et al., 2011) were crossed to Clp1K/+
animals and maintained in heterozygous form on a c57Bl/6
background. The offspring were genotyped by allele-specific
PCR primer sets including 5′-GGA TCA CTC TCG GCA TGG
AC-3′ forward and 5′-GGG CGT CCT CAT ACC TAG GT-3′
reverse primers.
Experimental animals were housed in either specific pathogen
free or conventional animal facilities. All animal experiments
were approved by the Animal Experimentation Review Board of
the Semmelweis University and the Government Office for Pest
County (Hungary).
Timed Matings and Handling of Late
Gestation Embryos and Newborns
Clp1K/+ heterozygous animals were used to set up overnight
timed matings. To examine prenatal lung morphology and
development before air exposure and extra-uterine respiratory
changes, the embryos were sacrificed in utero by immersing the
gravid uterus into ice-cold PBS for 40 min before harvesting
the embryos from the uterus under fluid as described before
(Jakus et al., 2014).
Embryos were collected at E14.5, E15.5, E16.5, E17.5, E18.5,
and E19.5. Cesarean sections were performed at E19.5 followed
by the rapid removal of the embryos from the uterus and
their manual stimulation. Naturally born and cesarean section
newborns were monitored for 2 h after birth and scored after
20–30 min. A skeletal muscle activity score (0–5) system was
used in which the general skeletal muscle activity of the newborn
was assessed including the movements [no movements or only
after stimulation, spontaneous limited movements, poor motor
activity, good motor activity, and excellent motor activity (0–4)]
and respiration [no breathing or gasping, normal breathing (0–
1)]. A viability score system (0–7) was also used in which the
newborns were scored based on their activity and movements
[no movements or only after stimulation, spontaneous limited
movements, poor motor activity, good motor activity, and
excellent motor activity (0–4)], appearance [cyanotic or normal
color (0–1)], breathing [no breathing or gasping, normal
breathing (0–1)], and breathing activity 60 min post birth (0–
1). Thereafter, tail samples were collected for genotyping, and
tissues were harvested from the embryos and newborns. The
whole chest, isolated lungs, gut, and skin were used for histology,
weight, and DNA content measurements.
Histological Processes and
Immunohistochemistry
Embryonic and newborn tissues were fixed in 4%
paraformaldehyde (Sigma-Aldrich) overnight on 4◦C,
dehydrated in 50, 70, 95, and 100% ethanol, then embedded
in paraffin using a Leica EG1150H embedding station. Seven-
micrometer-thick sections were generated using a HM340E
Thermo Scientific microtome, and processed for hematoxylin–
eosin (HE) (Leica), periodic acid-Schiff (PAS) (Sigma-Aldrich),
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trichrome (Sigma-Aldrich), and immunohistochemistry staining.
The following primary antibodies were used for immunostaining:
anti-LYVE1 (R&D Systems, AF2125), anti-PROX1 (Angiobio,
11-002P), anti-VEGRF3 (R&D, AF743) anti-CC10 (Santa Cruz
Biotechnology, Inc., sc-9772), anti-proSPC (Merck, AB3786),
anti-α-SMA (Abcam, ab124964), anti-Desmin (Dako, M0760),
anti-PDPN (R&D Systems, AF3244), anti-PDGFRα (Cell
Signaling Technology, 3164), anti-PDGFRβ (Cell Signaling
Technology, 3169), anti-Vimentin (Cell Signaling Technology,
5741), anti-PECAM1 (R&D Systems, MAB3628), and anti-NG2
(EMD Millipore, AB5320). As secondary antibodies Alexa Fluor
488 and 568 conjugated anti-goat or anti-rabbit antibodies
(Life Technologies) were used. As a nucleus staining DAPI
containing mounting medium (Vector Laboratories) was used.
Microscopic images were taken by a Nikon ECLIPSE Ni-U
microscope connected to a Nikon DS-Ri2 camera. Alveolar area
(averaging 8–10 fields of view per embryo) and septal thickness
(averaging 80–100 measurements per embryo), lymphatic
vessel area (average of all visible pulmonary lymphatic vessels
per embryo per section and normalized for the mean area
of the littermate controls) measurements were performed in
NIS-Elements Imaging Software (Nikon) using a 40× dry
objective (40× images). Different structures and cell types of
immunofluorescent images were quantified using Fiji software
(Schindelin et al., 2012). PDPN positive cells, Desmin positive
cells, PDGFRα positive cells, NG2 positive cells, and Vimentin
positive cells were counted on an area of 100 µm ∗ 100 µm. CC10
positive cells, SPC positive cells, LYVE1 and PROX1 positive
structures, PDGFRβ positive structures, and VEGFR3 positive
structures were counted on the whole field of view of 40×
images. PECAM positive structures and α-SMA positive vascular
structures were counted on the whole field of view of 20×
images. Alveolar area was measured using “Freehand selections”
tool and was extracted from the area of the examined area thus
the area of the interstitial tissue calculated. All cell counts (CC10,
SPC, PDPN, PDGFRα, NG2, Desmin, and Vimentin) were
normalized to this calculated interstitial area. Vascular structure
counts (PDGFRβ, α-SMA, NG2, PECAM1, VEGFR3, PROX1,
and LYVE1) are shown as mean and SEM.
DNA Content Measurements
For total DNA content measurements, DNA was isolated
from whole lungs of Clp1K/K and littermate control E18.5
embryos using DNeasy blood and tissue isolation kit (Qiagen).
DNA concentration of the samples was determined by
NanoDrop OneC Microvolume UV–Vis Spectrophotometer
(Thermo Scientific).
Monitoring Pulmonary Lymphatic
Function in vivo
To monitor lymphatic function pregnant Clp1K/+ females time-
mated with Clp1K/+ males were anesthetized. 0.5 µl of 70 kDa
RhD (Life Technologies) at 10 mg/ml concentration was injected
through the uterus and chest wall into the lung of E18.5
Clp1K/K and littermate control embryos on Flt4YFP lymphatic
reporter background as described before (Jakus et al., 2014; Bálint
et al., 2020). Selective uptake and transport of large molecular
weight RhD in fluorescent reporter positive lymphatic vessels
were monitored 60 min after the injection by a fluorescent
Nikon SMZ25 stereomicroscope equipped with Nikon DS-
Ri2 camera. To quantify the transport of fluorescently labeled
macromolecules, the intensity of RhD signal was measured in
NIS-Elements Imaging Software (Nikon) in reporter positive
lymphatic vessels (the background intensity was subtracted).
After imaging, the tissue samples were collected for genotyping.
Monitoring FBMs in Clp1K/K and
Littermate Control Embryos in utero
Pregnant Clp1K/+ mice time-mated with Clp1K/+ males were
anesthetized by isoflurane. Medial laparotomy was performed
in a supine position and the uterus was carefully externalized.
Embryos of pregnant mice were scanned by using a micro-
ultrasound imaging unit (Visualsonics, Vevo 3100 imaging
system) equipped with an ultrahigh frequency MX400 transducer
(30 MHz, 55 frames per second) at E18.5. Sudden displacement
of the diaphragm was considered as a FBM when it was
followed by expansion of the ribcage. Two minutes long videos
were recorded and FBMs were counted by a blinded, trained
observer. Tissue samples from embryos were collected for
genotyping after scanning.
Presentation of Data and Statistical
Analysis
Experiments were performed the indicated number of times.
Macroscopic pictures and microscopic images are representative
of three or more independent experiments. For all experiments,
investigators were blinded for the origin of embryos and
newborns until the end of the analysis. Image processing and
analysis were performed using NIS-Elements Imaging (Nikon),
Fiji Software (NIH), and Adobe Photoshop. Results are shown
as mean and SEM. Statistical analyses were performed using
GraphPad Prism 7.0 and Microsoft Office Excel software
programs. Specific statistical tests are presented in the figure
legend for each experiment. P-values <0.05 were considered
statistically significant.
RESULTS
Clp1K/K Embryos and Newborns Exhibit
Impaired Skeletal Muscle Function
Including FBMs, Cyanosis, and Die
Shortly After Birth
Clp1K/K mice carrying a kinase dead CLP1 RNA kinase were
reported to develop a progressive loss of motoneurons on the
c57Bl/6 genetic background (Hanada et al., 2013). First, we tested
the phenotype of Clp1K/K newborns. As expected, the Clp1K/K
newborns showed cyanosis, signs of acute respiratory failure,
and died shortly after natural birth or cesarean section (most
of them within 30 min) (Figure 1A). After birth, the skeletal
muscle function in Clp1K/K newborns was greatly impaired
compared to the control littermates as it is represented in
Supplementary Movie S1. In accordance, the skeletal muscle
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FIGURE 1 | Clp1K/K newborns show impaired skeletal muscle activity, develop respiratory failure, and die after birth. (A) Appearance of newborn Clp1+/+ and
Clp1K/K littermates on a c57Bl/6 genetic background. Representative images are shown of 15–19 embryos from six litters. (B) Overall skeletal muscle activity score
of newborn Clp1+/+ and Clp1K/K littermates on a c57Bl/6 genetic background. Quantitative data are shown as mean and SEM of 15–19 embryos from six litters
[∗∗∗∗P < 0.0001 (two-tailed t-test)]. (C) Viability score of newborn Clp1+/+ and Clp1K/K littermates on a c57Bl/6 genetic background. Quantitative data are shown
as mean and SEM of 15–19 embryos from six litters [∗∗∗∗P < 0.0001 (two-tailed t-test)]. (D) Total weight of control (Clp1+/+ or ClpK/+) and Clp1K/K newborns.
Quantitative data are shown as mean and SEM of three to eight embryos from one litter [P = 0.1868 (two-tailed t-test)]. (E) Representative images of lung
morphology shown by HE staining of newborn Clp1+/+ and Clp1K/K littermates on a c57Bl/6 background 60 min after birth. Representative images are shown of
five newborns of each group. Bars, 50 µm. (F,G) Quantitative data for alveolar area (F) and alveolar septal thickness (G) are represented in newborn lungs of
Clp1+/+ and Clp1K/K littermates on a c57Bl/6 genetic background [mean and SEM, n = 5 per group, ∗∗P = 0.0090 for alveolar area and ∗∗P = 0.0030 for septal
thickness (two-tailed t-test)].
activity score and the viability score of Clp1K/K newborns
were also greatly reduced compared to the littermate controls
(∗∗∗∗P = 6.94 ∗ 10−6 for skeletal muscle activity score and
∗∗∗∗P = 5.92 ∗ 10−5 for viability) (Figures 1B,C). Of note,
the visible size (Figure 1A) and measured weight (P = 0.1868)
(Figure 1D) of Clp1K/K newborns were not reduced compared
to the littermate control newborns. HE staining of the newborn
lungs revealed unaltered structure with reduced alveolar area
and thickened alveolar wall in the lung of Clp1K/K newborns
(∗∗P = 0.0090 for alveolar area and ∗∗P = 0.0030 for septal
thickness) (Figures 1E–G). FBMs have been described in mouse
embryos during late gestation, but effectively monitoring them in
mouse genetic models has great limitations (Niblock et al., 2020;
and discussed below). Despite these limitations we observed
FBMs in Clp1+/+ and Clp1K/+ control embryos at E18.5
[2.67 ± 1.12 FBMs in 2 min (mean and SEM); five out
of six control embryos performed FBMs], and no FBM was
detectable in 1 Clp1K/K embryo with normal heart activity in
one litter (Supplementary Movies S2, S3). Importantly, it has
been reported that breathing-like episodes correlate well with
the breathing activity and movements of the newborn after birth
(Niblock et al., 2020). Collectively, our results confirmed that
Clp1K/K genetic model with impaired skeletal muscle function
involving the respiratory muscles is an excellent tool to study
the possible role of mechanical forces and FBMs during the late
gestation period.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 5 March 2020 | Volume 8 | Article 136
fbioe-08-00136 March 4, 2020 Time: 16:56 # 6
Szoták-Ajtay et al. Fetal Breathing Movements and Pulmonary Lymphatics
Late Gestation Clp1K/K Embryos Do Not
Exhibit Altered Expression of Molecular
Markers of Lung Development
Next, we characterized the molecular lung development in
Clp1K/K embryos on the c57Bl/6 genetic background. Late lung
developmental markers for lung Club (Clara) cells (CC10),
alveolar type II cells (SPC), type I cells (PDPN), mesenchyme
(PDGFRα, Vimentin, Desmin), vascular smooth muscle cells
and pericytes (PDGFRβ, NG2, and α-SMA), lung endothelial
cells (PECAM1), and pulmonary LECs (VEGFR3, PROX1,
and LYVE1) showed normal expression levels with no major
difference in the number of cells or vascular structures in
Clp1K/K embryos compared to the Clp1+/+ littermates at E18.5
shown by representative images and quantification (Figure 2 and
Supplementary Table S1). Collectively, analyzing the expression
of cellular and molecular lung developmental markers indicated
unaltered pulmonary development inClp1K/K embryos. The only
observed alteration in late gestation Clp1K/K embryos was the
marked dilation of pulmonary lymphatic vessels in the embryonic
lungs compared to the control lungs (note the arrows in the
figure panels) shown by LYVE1, PROX1, and VEGFR3 lymphatic
markers (Figure 2).
Late Gestation Lung of Clp1K/K Embryos
With Impaired Skeletal Muscle Function
Shows Thickened Alveolar Septum and
Reduced Alveolar Area Before Air
Inflation
To study the possible impact of FBMs on the structure of the
developing lung, lung morphology in Clp1K/K embryos revealed
no detectable changes before E16.5 compared to the controls
(Figure 3A). We observed increased septal wall thickness and
reduced alveolar space area at E17.5 compared to the controls,
and these changes were also present at E18.5 in utero before
air inflation of the lung in Clp1K/K embryos (∗P = 0.0165 for
alveolar area and ∗∗P = 0.0018 for septal thickness at E17.5
and ∗P = 0.0103 for alveolar area and ∗P = 0.0348 for septal
thickness at E18.5) (Figures 3A–C). Of note, the DNA content
and dry weights of the Clp1K/K embryonic lungs at E18.5
were not reduced compared to control littermates, which results
are consistent with our molecular findings supporting normal
growth and maturation of lung cell types (P = 0.1753 for DNA
content and P = 0.1452 for dry weight) (Figures 3D,E and
Supplementary Table S1). Trichrome staining and PAS staining
also revealed normal lung structure in Clp1K/K embryos but
alveolar interstitial thickness was increased and the alveolar area
was reduced compared to the control at E18.5 (Figures 3F,G).
Glycogen as a surfactant precursor accumulates in the developing
lung if surfactant production is blocked (Bourbon et al.,
1982). Importantly, PAS staining indicated normal levels of
glycogen in the alveolar cells of Clp1K/K embryonic lungs at
E18.5 (Figure 3G).
Collectively, the studies of the Clp1K/K genetic model suggest
the importance of FBMs in the regulation of lung morphology
and expansion during late gestation, but not influencing the
cellularity and growth of the embryonic lung. Of note, the
observed morphological changes in Clp1K/K embryos displaying
impaired FBMs are very similar to the phenotype of lymphatic-
deficient embryos (Jakus et al., 2014).
The Pulmonary Lymphatic Vessels Are
Markedly Dilated in Late Gestation
Clp1K/K Embryos With Impaired Skeletal
Muscle Function Before Air Inflation
Developing pulmonary lymphatic structures can be detected
at E14.5 in the embryonic lung (Figure 4A). Importantly, the
lymphatic vessels showed marked dilation at E17.5 in Clp1K/K
embryos, and the dilation was more apparent at E18.5 and
E19.5 compared to the littermate controls (∗P = 0.0443 at
E17.5; ∗∗P = 0.0073 at E18.5) (Figures 4A,B). In contrast, the
structure of the lymphatic vessels showed no difference compared
to the littermate controls in other organs including the small
intestine and the skin (Figure 4C). These results indicate that
the lymphatics are present and show unaltered development in
Clp1K/K embryos, but the lymphatic structures appear to be
markedly dilated in Clp1K/K embryos, which may indicate the
impairment of pulmonary lymphatic function.
The Presence of Lymphatic Function
Impairment in Late Gestation Lungs of
Clp1K/K Embryos
To monitor the pulmonary lymphatic function in late gestation
embryos, 70 kDa RhD was injected into the embryonic lung
of Clp1K/K and littermate control embryos on the Flt4YFP
lymphatic reporter genetic background at E18.5 through the
uterine wall and chest wall. Selective uptake and transport of
the fluorescently labeled macromolecule in reporter positive
pulmonary lymphatic vessels was detectable 60 min post injection
in Clp1K/+ control embryos. Importantly, the uptake and
transport of the labeled macromolecule in the YFP positive
lymphatic vessel indicating the lymphatic function was severely
reduced in Clp1K/K embryos at E18.5 compared to littermate
controls (∗P = 0.0151) (Figures 5A,B).
Postnatal Phenotype of Clp1K/K
Newborns on a Mixed Genetic
Background
It is thought that the phenotype of transgenic animals tends
to be less severe on a mixed genetic background than on a
pure inbred genetic background. In connection, it is documented
that lymphatic phenotypes are less severe on the NMRI
genetic background, serving as a permissive genetic background
(Karkkainen et al., 2001). Therefore, to study the possible
correlation of the skeletal muscle activity in late gestation
embryos with the prenatal lung phenotype and lymphatic
morphology we crossed the Clp1K/K genetic model to a c57Bl/6-
NMRI mixed genetic background. First, we characterized the
motility and viability of Clp1K/K newborns on this genetic
background (Figures 6A,B). The clinical score representing the
overall skeletal muscle activity score was reduced in Clp1K/K
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FIGURE 2 | Normal molecular and cellular lung development in late gestation Clp1K/K embryos. Immunostaining for CC10, SPC, PDPN, PDGFRα, PDGFRβ, NG2,
α-SMA, Desmin, Vimentin, PECAM1, VEGFR3, PROX1, LYVE1, and DAPI nuclear staining are shown in late gestation Clp1+/+ and Clp1K/K embryonic lungs at
E18.5. Representative images are shown of three to five independent experiments per group. Bars, 50 µm.
newborns on the c57Bl/6-NMRI mixed background compared
to the control newborn mice [59.57 ± 15.34% normalized to
the controls (mean and SEM)] (∗P = 0.0374) (Figure 6A). The
clinical score representing viability of the Clp1K/K newborns
was also reduced on the c57Bl/6-NMRI mixed background
compared to the controls but this difference was not significant
[64.7 ± 16.38% normalized to the controls (mean and SEM)]
(P = 0.0684) (Figure 6B). Note that the overall skeletal muscle
activity score of Clp1K/K newborns on the pure c57Bl/6 genetic
background is 29.6 ± 7.73% (mean and SEM) normalized to the
controls (∗∗∗∗P = 6.94 ∗ 10−6), and the clinical score representing
viability of the Clp1K/K newborns is 38.95 ± 8.98% (mean
and SEM) normalized to the controls (∗∗∗∗P = 5.92 ∗ 10−5)
(Figures 1B,C). These results indicate that there is a trend
suggesting that the newborn muscle function and viability is less
impaired in Clp1K/K newborns on c57Bl/6-NMRI mixed genetic
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FIGURE 3 | Thicker alveolar septum and reduced alveolar area in Clp1K/K embryos before air inflation of the lung. (A) Lung morphology shown by HE lung histology
of Clp1+/+ and Clp1K/K embryos before air inflation in utero at E14.5, E15.5, 16.5, E17.5, E18.5, and E19.5 on a c57Bl/6 genetic background. Representative
images are shown of two to four embryos per group from one to two litters. Bars, 50 µm. (B,C) Quantitative data for alveolar area (B) and alveolar septal thickness
(C) of Clp1+/+ and Clp1K/K embryonic lungs (E17.5 and E18.5) on a c57Bl/6 genetic background. Quantitative data are represented as mean and SEM from four to
five embryos in each group [∗P = 0.0165 at E17.5 and ∗P = 0.0103 at E18.5 for alveolar area and ∗∗P = 0.0018 at E17.5 and ∗P = 0.0348 at E18.5 for septal
thickness (two-tailed t-test)]. (D) Total DNA content of the lung shown as DNA concentration in late gestation control (Clp1+/+ and Clp1K/+) and Clp1K/K embryos
at E18.5. Quantitative data are shown as mean and SEM from five to six embryos in each group [P = 0.1753 (two-tailed t-test)]. (E) Dry weights of lung of late
gestation control (Clp1+/+ and Clp1K/+) and Clp1K/K embryos at E18.5. Quantitative data are shown as mean and SEM from 5 to 17 embryos in each group
[P = 0.1452 (two-tailed t-test)]. (F,G) Trichrome staining (F) and periodic acid-Schiff (PAS) staining (G) for levels of the surfactant precursor glycogen in the lungs of
Clp1+/+ and Clp1K/K embryos at E18.5. Representative images are shown of three embryos examined in each group. Bars, 50 µm.
background than on the pure c57Bl/6 background. Moreover,
the lung morphological changes were also less severe on the
c57Bl/6-NMRI mixed genetic background than on the c57Bl/6
background in Clp1K/K newborns (Figure 6C). Importantly,
3 Clp1K/K mice out of 134 pups in 15 litters survived to
P21 on c57Bl/6-NMRI mixed background, while no Clp1K/K
mouse was found to survive to P21out of 86 mice in 19 litters
on the pure c57Bl/6 genetic background. These comparisons
indicate that the skeletal muscle function is more intact in
Clp1K/K newborns on the c57Bl/6-NMRI mixed background
than it is on the pure c57Bl/6 genetic background. Importantly,
the lymphatic vessels are less dilated in Clp1K/K newborns on
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FIGURE 4 | Dilated pulmonary lymphatic vessels in late gestation Clp1K/K embryos. (A) Morphology of lymphatic vessels shown by immunostaining for LYVE1,
PROX1 lymphatic markers, and DAPI nuclear staining at different stages of embryonic life (E14.5, E15.5, 16.5, E17.5, E18.5, and E19.5) of Clp1+/+ and Clp1K/K
embryonic lungs on a c57Bl/6 genetic background. Representative images are shown of two to four embryos per each group. Bars, 50 µm. (B) Normalized
lymphatic vessel area in Clp1+/+ and Clp1K/K embryos at E17.5 and E18.5 before air inflation on a c57Bl/6 genetic background. Quantitative data are shown as
mean and SEM of four embryos in each group from three litters [∗P = 0.0443 at E17.5; ∗∗P = 0.0073 at E18.5 (two-tailed t-test)]. (C) Lymphatic morphology shown
by immunostaining for LYVE1, PROX1, and nuclear DAPI staining in the skin and small intestine of Clp1+/+ and Clp1K/K embryos at E18.5 on a c57Bl/6 genetic
background. Representative images are shown of four embryos from three litters. Bars, 50 µm.
the c57Bl/6-NMRI mixed background if we compare them to
the pulmonary lymphatic vessels in Clp1K/K newborns on the
c57Bl/6 genetic background (Figure 6D).
Prenatal Phenotype of Clp1K/K Embryos
on a Mixed Genetic Background With
Less Impaired Skeletal Muscle Function
Thereafter, we characterized the lung morphology of Clp1K/K
embryos on the c57Bl/6-NMRI mixed genetic background at
E18.5 before the air inflation of the embryonic lungs. The
results indicate that the alveolar septum is thickened, but the
alveolar area is not significantly reduced in late gestation Clp1K/K
embryos compared to the controls on a c57Bl/6-NMRI mixed
genetic background with less impaired skeletal muscle function
(∗P = 0.0281 for septal thickness and P = 0.0561 for alveolar
area) (Figures 7A–C). In addition, the pulmonary lymphatics
are less dilated in the late gestation Clp1K/K embryos with less
impaired skeletal muscle function compared to the controls on
a mixed genetic background (P = 0.8776) [111.04 ± 10.64%
normalized to the controls (mean and SEM)] (Figures 7D,E)
than in Clp1K/K embryos at E18.5 on the pure c57Bl/6 genetic
background (∗∗P = 0.0073) [471.49 ± 69.3% normalized to the
controls (mean and SEM)] (Figure 4).
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FIGURE 5 | Impaired pulmonary lymphatic function in late gestation Clp1K/K embryos. (A) Monitoring the uptake and transport of fluorescently labeled
macromolecules by pulmonary lymphatic vessels in control (Clp1K/+) and Clp1K/K E18.5 embryonic lungs carrying Flt4YFP lymphatic reporter allele on a c57Bl/6
genetic background injected with 70 kDa RhD into the lung through the chest wall and uterus. Representative images are shown of three to four embryos per group
from five litters. Bars, 250 µm. (B) Quantitative data for the uptake of fluorescently labeled macromolecules (RhD) into YFP positive lymphatic vessels (intensity of
RhD signal in fluorescently labeled pulmonary lymphatic vessels, the background intensity was subtracted) are shown as mean and SEM at E18.5 in control
(Clp1+/+, Clp1K/+) and Clp1K/K embryos from three to four embryos per each group from five litters [∗P = 0.0151 (two-tailed t-test)].
These results suggest a trend indicating the correlation
between the severity of the impairment of the skeletal muscle
function and the dilation of pulmonary lymphatics in the
developing lung.
DISCUSSION
In our study we used Clp1K/K CLP1 kinase-dead mice which
lose the innervation of skeletal muscle from E16.5 onward
(Hanada et al., 2013). Our experiments confirmed the findings
of the prior report (Hanada et al., 2013) demonstrating that
Clp1K/K newborns show impaired motor function resulting in
fatal respiratory failure with cyanosis after birth indicated by the
reduced skeletal muscle activity and reduced viability of Clp1K/K
newborns (Figure 1 and Supplementary Movie S1). Importantly,
it has been reported that breathing-like episodes of the late
gestation embryo correlate well with the motor functions and
breathing activity of the newborn after birth, but the frequency
of FBMs is less in utero than the frequency of the breathing after
birth (Niblock et al., 2020). Therefore, our findings indicate that
the Clp1K/K genetic model serves as an excellent tool to study the
possible role of FBMs on pulmonary development in utero, which
periodic movements are present during late gestation.
Fetal breathing movements during late gestation have been
documented not only in large animals and humans, but also
in mice. In early studies premature Cesarean sections followed
by plethysmography, and monitoring breathing-like movements
in reduced preparations were performed (Viemari et al., 2003;
Thoby-Brisson et al., 2005). Later the embryos one by one
were externalized for imaging studies (Kleven and Ronca, 2009).
A recent report imaging non-externalized embryos in utero
demonstrated the presence of FBMs in wild-type unanesthetized
pregnant mice by ultrasound, and described that FBMs can show
sporadic, clustered, or rhythmic patterns in mice, and there is
a tendency of their increase with embryonic age (Niblock et al.,
2020). The authors also emphasized that detecting FBMs in utero
in genetic mouse models has great limitations. The anesthesia of
the pregnant female, reduced preparation, externalization of the
embryos, or other mechanical manipulation may influence the
FBMs. In connection, Brown et al. (2006) were not able to detect
FBMs in mouse embryos probably due to the anesthesia. The best
way to monitor FBMs is to perform imaging in the abdomen of
the female without externalization of the embryos and uterus but
in this case it is difficult or impossible to determine that which
body part belongs to an individual embryo especially in larger
litters (Niblock et al., 2020; and data not shown). Externalization
of the uterus allows the precise identification of each embryo
for FBM measurements by in vivo ultrasound and corresponding
genotyping. Limitations of this method include mechanical
disturbance of utero-placental circulation and a drop in body
temperature. Therefore, only a limited time frame is available to
observe FBMs of the embryos in this setting, while it is possible
an extended period of time (more than 10 min) is needed to
effectively document periodic FBMs in the case of each embryo. It
has also been shown as another difficulty that FBMs are primarily
present during REM sleep in sheep and cease before delivery
(Dawes et al., 1972; Greer et al., 2006). Despite these significant
limitations we observed FBMs in Clp1+/+ and Clp1K/+ control
embryos at E18.5 [2.67 ± 1.12 FBMs in 2 min (mean and SEM);
five out of six control embryos performed FBMs], and no FBM
was detectable in 1 Clp1K/K embryo with normal heart activity in
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FIGURE 6 | Postnatal phenotype of Clp1K/K newborns on a c57Bl/6-NMRI
mixed genetic background. (A) Overall skeletal muscle activity score of
newborn Clp1+/+ and Clp1K/K littermates on a c57Bl/6-NMRI mixed genetic
background. Quantitative data are represented as mean and SEM from 9 to
12 newborns in each group [∗P = 0.0374 (two-tailed t-test)]. (B) Viability score
of newborn Clp1+/+ and Clp1K/K littermates on a c57Bl/6-NMRI mixed
genetic background. Quantitative data are represented as mean and SEM
from 9 to 12 newborns in each group [P = 0.0684 (two-tailed t-test)]. (C) Lung
morphology of newborn Clp1+/+ and Clp1K/K littermates on c57Bl/6 and
c57Bl/6-NMRI mixed genetic backgrounds shown by HE histology.
Representative images are shown from seven newborns from three litters.
Bars, 50 µm. (D) Visualization of pulmonary lymphatics in Clp1+/+ and
Clp1K/K newborns on c57Bl/6 and c57Bl/6-NMRI mixed genetic
backgrounds. Representative images are shown for LYVE1 immunostaining
and DAPI from five newborns per group in two litters. Bars, 50 µm.
one litter (Supplementary Movies S2, S3). Of note, we also had
two litters at E18.5 showing no or minimal FBM activity in most
of the late gestation embryos (data not shown). Further studies
will be needed to develop imaging techniques to more effectively
monitor FBMs in mouse genetic models.
We found that the expression of molecular and cellular
markers of lung development is not altered in Clp1K/K embryos
using a number of developmental markers including alveolar type
II and I cell, Club (Clara) cell, mesenchymal cell, and vascular
cell markers (Figure 2 and Supplementary Table S1). These
findings are in accordance with a previous report, in which
the expression of surfactant protein C and A in late gestation
Clp1K/K embryos was analyzed (Hanada et al., 2013). Another
prior study, in which the authors aspirated the amniotic fluid
to study the possible role of the mechanical forces on lung
development indicated that amniotic fluid inhalation influences
alveolar type I cell differentiation, whereas FGF10-mediated
ERK1/2 signaling induces a protrusive structure in some cells,
which process protects from flattening to specify alveolar type II
fate (Li et al., 2018). In connection to this report, it is important
to note that the leakage or drainage of the amniotic fluid may
affect not only FBMs but also the volume and function of the
organs. Therefore, this model provides important results about
the possible role of mechanical forces and fluid volumes on
organ development, but they have great limitations to reveal the
physiological role of FBMs.
Importantly, our studies revealed that the alveolar septa are
thicker and the alveolar area is reduced in late gestation Clp1K/K
embryos before air inflation suggesting that mechanical forces
including FBMs influence the expansion of the developing lung
(Figure 3). Former studies also indicated the defect in lung
expansion in models using transection of the spinal cord above
the phrenic nucleus or the section of the phrenic nerve, and
concluded the presence of lung hypoplasia, while a part of the
results indicated that the cellularity represented by the total DNA
content of the developing lung is not affected (Fewell et al., 1981;
Liggins et al., 1981; Bamford et al., 1992). Of note, the surgical
approaches in these former studies manipulating the spinal cord
or phrenic nerve are heroic and may influence a number of other
physiological processes in addition to FBMs.
It is known that mechanical forces influence the growth rate
of the embryo and the skeletal system from the early embryonic
period (Felsenthal and Zelzer, 2017). Therefore, it should be
noted that other reports which use genetic models in which
embryos are paralyzed from the early embryonic period to
study the possible role of FBMs described severe defects of the
whole skeleton. These changes are represented in the smaller
size and reduced growth rate of the embryo, indicating the great
limitations of these experimental systems (Sandler et al., 1994;
Tseng et al., 2000). Importantly, the growth rate of the Clp1K/K
was not reduced in our studies, which is a great advantage of our
experimental system (Figures 1A–D).
In addition, the Clp1K/K genotype does not influence
molecular and cellular lung development (Figure 2 and
Supplementary Table S1). Lung hypoplasia was also not present
in late gestation Clp1K/K embryos showing normal DNA content
and dry weights of the embryonic lungs (Figures 3D,E). This is in
contrast to former studies which concluded the presence of lung
hypoplasia in experiments trying to define the possible role of
mechanical forces on lung development, but these findings also
suggest the great limitation of the former studies using surgical
approaches, modulating general growth rate of the embryo and
influencing fluid volumes as discussed above.
Our prior studies indicated that parallel mechanisms prepare
the developing lung for inflation at birth (Jakus et al., 2014).
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FIGURE 7 | Prenatal phenotype of Clp1K/K embryos on a mixed genetic background with less impaired skeletal muscle function. (A) Lung morphology shown by
HE histology of Clp1K/+ and Clp1K/K embryos at E18.5 on a c57Bl/6-NMRI mixed background. Representative images are shown of three embryos per group from
one litter. Bars, 50 µm. (B,C) Quantitative data for alveolar area (B) and alveolar septal thickness (C) of embryonic lungs of Clp1K/+ and Clp1K/K littermates on a
c57Bl/6-NMRI mixed background at E18.5 represented as mean and SEM in three embryos in each group from one litter [P = 0.0561 for alveolar area and
∗P = 0.0281 for the septal thickness (two-tailed t-test)]. (D) Morphology of pulmonary lymphatic vessels shown by LYVE1 immunostaining in E18.5 late gestation
Clp1K/+ and Clp1K/K embryonic lungs on a c57Bl/6-NMRI mixed background. Representative images are shown of three embryos in each group from one litter.
Bars, 50 µm. (E) Quantitative data for normalized lymphatic vessel area in Clp1K/+ and Clp1K/K embryos at E18.5 are shown as mean and SEM of three embryos in
each group from one litter [P = 0.8776 (two-tailed t-test)].
In addition to surfactant, prenatal lymphatic function also
plays an important role to prepare the developing lung for
inflation at birth (Jakus et al., 2014; Aspelund et al., 2016).
Our former study using lymphatic-deficient genetic models
demonstrated the importance of prenatal lymphatic function
as a regulator of lung inflation at birth by inducing the
expansion and increasing the compliance of the developing lung
in preparation for the first breath (Jakus et al., 2014; Aspelund
et al., 2016). Our current study revealed that the prenatal
phenotype of the developing lung in late gestation Clp1K/K
embryos is very similar with thickened alveolar septa and reduced
alveolar area to the phenotype that was reported in lymphatic-
deficient animals (Jakus et al., 2014). Importantly, pulmonary
lymphatics are present in the embryonic Clp1K/K lung, but
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they are markedly dilated (Figure 4). Moreover, the prenatal
pulmonary lymphatic function is reduced in Clp1K/K embryos
(Figure 5). We also detected a trend indicating the correlation
between the severity of the impairment of the skeletal muscle
function in Clp1K/K embryos and the dilation of pulmonary
lymphatics in the developing lung on a mixed genetic background
(Figures 6, 7). Our results have revealed that Clp1K/K mice show
impaired motor functions including FBMs, and late gestation
Clp1K/K embryos display reduced prenatal lymphatic function
and impaired lung expansion represented as thickened alveolar
septa and reduced alveolar area in preparation of the developing
lung for inflation at birth.
Here we found that the skeletal muscle dysfunction is less
severe in Clp1K/K mice on the c57Bl/6-NMRI mixed genetic
background than it is on the pure c57Bl/6 genetic background.
Of note, Hanada et al. (2013) also reported the most severe
motor neuron loss and paralysis of Clp1K/K embryos on the
c57Bl/6 genetic background. No surviving Clp1K/K newborn was
reported on the c57Bl/6 genetic background in their study. It
would be an interesting future project to reveal the molecular
mechanism why the phenotype affecting the skeletal muscles
is less severe on the c57Bl/6-NMRI mixed genetic background.
Here we wanted to demonstrate that there is a trend, which
indicates the correlation between the severity of the impairment
of the skeletal muscle function and the dilation of pulmonary
lymphatics in the developing lung.
In connection, our recent study revealed the lack of smooth
muscle coverage of the collecting pulmonary lymphatics in
contrast to other collecting lymphatic vessels in the body
(Tammela and Alitalo, 2010; Aspelund et al., 2016; Petrova and
Koh, 2018; Outtz Reed et al., 2019), implying that changes in
pressure and respiratory movements may be a driver of lymphatic
function in the lung as opposed to contraction of the vessel itself.
This suggests that lymphatic function, both pre- and postnatally
may be dependent on breathing movements. One intriguing
interpretation of the data presented here is that the mechanism
how FBMs regulate the expansion of the developing lung is
to stimulate the pulmonary lymphatic function before the air
inflation of the lung and the presence of postnatal respiratory
activity. It would be an important next step in the project
to test possible pharmacological approaches (e.g. caffeine) in
large animal models to stimulate FBMs during late gestation,
which treatment may prevent neonatal respiratory failure in
preterm infants.
The Clp1K/K late gestation embryos exhibit a progressive loss
of motor neurons and skeletal muscle activity from E16.5 onward
during late gestation, and it is not possible to rescue the motor
neuron loss at or after birth. We think that it is as good or better
model for studying the impact of FBMs on lung development
than the other approaches (leakage or drainage of the amniotic
fluid, performing heroic surgery, paralysis starting at an early
developmental stage, etc.). To provide further experimental proof
has great limitations. The first possible way would be to rescue
the lymphatic function in late gestation Clp1K/K embryos. To
this end, it would be necessary to generate rhythmic contractions
of the chest, basically mimicking breathing like movements
in utero. This would be a possible way how the mechanical
forces generated around the pulmonary lymphatic vessels lacking
smooth muscle coverage could rescue the lymphatic function in
these paralyzed late gestation Clp1K/K embryos, but it is not a
feasible experiment. The second possible additional way would
be to use a model in which motor activity and FBMs are impaired
during late gestation before birth, but the embryos show normal
respiration after birth. We do not know about a model like this.
The third possible way would be to set up a mouse intensive
care unit, in which it would be possible to treat an anesthetized,
mechanically ventilated pregnant wild-type mouse during late
gestation with skeletal muscle relaxant drugs. This experiment
would also be very challenging. In all possible models it would
be useful to monitor FBMs and lymphatic function in each
embryo in parallel in utero, but it is not feasible to perform
this experiment in mouse embryos in vivo, especially for an
extended period of time.
Collectively, the characterization of the development of the
embryonic lung before air inflation in this study revealed that the
alveolar septa are thicker, and the alveolar area is reduced in late
gestationClp1K/K embryos, which model shows impaired skeletal
muscle function including FBMs, while the molecular lung
development is not affected. Importantly, pulmonary lymphatic
vessels appear to be dilated and the prenatal pulmonary
lymphatic function is reduced in Clp1K/K embryos. Thus, our
results have revealed that Clp1K/K mice show impaired motor
functions including FBMs, and late gestation Clp1K/K embryos
display reduced prenatal lymphatic function and impaired lung
expansion represented as thickened alveolar septa and reduced
alveolar area in preparation of the developing lung for inflation
at birth. These findings suggest a possible mechanism that FBMs,
similarly to breathing movements after birth, stimulate prenatal
lymphatic function in pulmonary collecting lymphatics lacking
smooth muscle coverage to prepare the developing lung for
inflation and gas exchange at birth. Moreover, these results raise
the possibility that stimulating FBMs during late gestation might
be an effective way to reduce the risk of the development of
neonatal respiratory failure.
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TABLE S1 | Quantification of lung developmental and structural markers in
Clp1+/+ and Clp1K/K embryos at E18.5. Quantification of structures or cell types
in immunofluorescent images. Cell counts are presented as cell/mm2 (CC10,
SPC, PDPN, PDGFRα, NG2, Desmin, and Vimentin). Vascular structure counts
(PDGFRβ, α-SMA, PECAM1, VEGFR3, and PROX1/LYVE1) are shown as mean
and SEM. PDPN, Desmin, PDGFRα, NG2, and Vimentin are quantified on an area
of 100 µm ∗ 100 µm. CC10, SPC, LYVE1 and PROX1, PDGFRβ, and VEGFR3
are quantified on a field of view of images made with a 40× objective. PECAM and
α-SMA are quantified on a field of view of images made with a 20× objective. No
data showed significant difference between the two groups (mean ± SEM,
two-tailed t-test).
MOVIE S1 | Representative movie of Clp1+/+ and Clp1K/K newborn mice
20 min after birth.
MOVIE S2 | Representative ultrasound movie of late gestation Clp1K/+ control
embryo at E18.5. Note the respiration of the pregnant female.
MOVIE S3 | Representative ultrasound movie of late gestation Clp1K/K embryo at
E18.5. Note the respiration of the pregnant female.
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